They think it could transform the lives of people with MS
Breakthrough treatment for people with multiple sclerosis (MS) has been identified by experts at Cambridge University following decades of research.
Specialists have spent more than 30 years exploring the possibilities of a new drug treatment and now they think it could transform the lives of people with MS.
The autoimmune disease sees the body’s immune system attack good cells, resulting in irreparable damage to nerves, leading to disabilities. It affects almost 100,000 people in the UK.
But successful results from a trial called CARE-MS2 have just emerged.
The trial was overseen by Prof Alastair Compston, head of the Department of Clinical Neurosciences, who began to explore the use of a drug called alemtuzumab, then a treatment for leukaemia, as a treatment for MS in 1991 – other scientists had been looking at the drug since 1975.
His research partner Dr Alasdair Coles said: “Three important results emerge from these trials.
“First, they show that just eight days of alemtuzumab significantly reduces the risk of having another relapse of multiple sclerosis or becoming disabled over the next three to five years, compared to the standard active drug, interferon-beta.
Read more . . .
Bookmark this page for “multiple sclerosis” and check back regularly as these articles update on a very frequent basis. The view is set to “news”. Try clicking on “video” and “2” for more articles.